DSCSA in Maine.
In Maine, every manufacturer and wholesaler whose prescription drugs are distributed in the state, wherever it is located, needs an annual licence from the Maine Board of Pharmacy, while the Drug Supply Chain Security Act's tracing rules apply as they do in every state.
Under 32 M.R.S. section 13758, every manufacturer and wholesaler whose products are distributed in Maine, whether located in the state or outside it, must be licensed by the Maine Board of Pharmacy, and the licence is renewed every year. Distributing prescription drugs in Maine without it is unlawful.
DSCSA in Maine, in three facts.
US DSCSA · federal tracing rules · Maine licensing · authorized trading partners.
Under 32 M.R.S. section 13758(1), (2) and (6), every manufacturer and wholesaler whose products are distributed in Maine in any manner, whether located within or outside the state, must be licensed by the Maine Board of Pharmacy, and it is unlawful to distribute prescription drugs in Maine without that licence.
Source: Maine Revised Statutes, Title 32, section 13758, Licensure (Office of the Revisor of Statutes, read 21 November 2026)Under 32 M.R.S. section 13758(1), the Legislature's stated intent is that the Maine Board of Pharmacy may not adopt rules for companies without wholesale or manufacturing facilities in Maine that are more restrictive than federal law or regulation, and under section 13751(1) manufacturers and wholesalers obtain their licence annually.
Source: Maine Revised Statutes, Title 32, section 13758, Licensure (Office of the Revisor of Statutes, read 21 November 2026)Under 32 M.R.S. section 13758(4), as amended by Public Law 2025, chapter 544, the licence form states the applicant's name, address, day and 24-hour phone numbers, ownership status and manufacturer or wholesaler designation, its DEA and FDA registration numbers where it has them, and is signed by an owner or officer; a registration number obtained later is filed with the Board once obtained.
Source: Maine Revised Statutes, Title 32, section 13758, Licensure (Office of the Revisor of Statutes, read 21 November 2026)
Federal tracing, Maine licensing.
A licence wherever you are located
Section 13758 requires all manufacturers and wholesalers whose products are distributed in Maine in any manner to be licensed by the Board of Pharmacy, within or outside the state. It is unlawful to distribute prescription drugs in Maine without that licence, and section 13751 makes the licence annual. Employees of a licensed company do not need their own licence.
No stricter rules for companies outside Maine
The Legislature's stated intent in section 13758 is that the Board may not adopt rules for companies without wholesale or manufacturing facilities in Maine that are more restrictive than federal law or regulation. Since Public Law 2025, chapter 544, the licence form asks for the applicant's DEA and FDA registration numbers where it has them, and is signed by an owner or officer.
The tracing rules are federal
Product identifiers, electronic transaction data, verification and six-year records are the same in every state. DSCSA sets one national standard and a state may not add its own tracing rules on top.
Report the licence to FDA
Wholesale distributors and 3PLs report their state licences to FDA every year. Your trading partners can look you up in FDA's database, and you can look them up.
The timeline, as it stands.
The federal dates are the same in every state. The last exemption still running is for small dispensers, and it ends on 27 November 2027.
Three moves that de-risk the deadline.
Check your Maine licence details
Confirm each manufacturer and wholesaler entity that ships into Maine holds a current Board of Pharmacy licence, renewed each year, and that any DEA or FDA registration number obtained after you applied has been filed with the Board.
Keep proof of every partner's licence
For each supplier and customer in Maine, keep a dated copy of the licence check. Under DSCSA you may trade only with authorized trading partners, and an auditor will ask how you know.
Test a trace
Pick one unit shipped or received last quarter and produce its transaction data. Wholesale distributors have one business day to answer FDA, and dispensers have two.
One record, whichever state.
Aeroz ties each unit's physical identity to its transaction record, so a scan in Maine produces the same evidence as a scan anywhere else: who held the unit, when, and whether it matched its data. The licence is yours to hold. We make the tracing side quick to prove.
DSCSA in Maine, answered.
Do I need a Maine wholesale drug distributor license?
Yes, if your prescription drugs are distributed in Maine. Section 13758 requires every manufacturer and wholesaler whose products are distributed in the state in any manner to be licensed by the Maine Board of Pharmacy, wherever it is located.
Who licenses drug wholesalers in Maine?
The Maine Board of Pharmacy, under Title 32, chapter 117 of the Maine Revised Statutes. Manufacturers and wholesalers obtain the licence annually.
Does Maine add rules for out-of-state wholesalers?
The statute says the Board may not adopt rules for companies without wholesale or manufacturing facilities in Maine that are more restrictive than federal law or regulation. Out-of-state companies still need the Maine licence.
Does Maine have its own DSCSA tracing rules?
No. DSCSA tracing is federal and the same in every state. Maine controls licensing, on top of the federal requirements.
Does Maine have its own track-and-trace rules?
No. DSCSA sets a single national standard for tracing prescription drugs, and a state may not set tracing requirements that differ from it. Maine controls licensing; the tracing duties come from federal law.
How do I check that a Maine trading partner is authorized?
Check its licence with the Maine Board of Pharmacy, and look it up in FDA's wholesale distributor and 3PL reporting database. Under DSCSA you may trade only with partners that hold a valid licence or registration.
Know exactly where you stand, in 14 days.
A fixed-fee Aeroz audit maps your products against DSCSA requirements for trading partners in Maine and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.